Money and motivation: A comparison of excess weight loss (EWL) in insured and uninsured patients undergoing laparoscopic sleeve gastrectomy (LSG)

2018 ◽  
Vol 14 (11) ◽  
pp. S124-S125
Author(s):  
Sabin J Warner-Smith
Keyword(s):  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Excess Weight Loss ◽  
Excess Weight ◽  
Uninsured Patients

Laparoscopic Sleeve Gastrectomy: Outcomes at a Military Training Center

2010 ◽  
Vol 76 (8) ◽  
pp. 835-840
Author(s):  
Robert D. Rice ◽  
Todd E. Simon ◽  
Jason M. Seery ◽  
James D. Frizzi ◽  
Farah A. Husain ◽  
...  
Keyword(s):  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Excess Weight Loss ◽  
Military Training ◽  
Excess Weight ◽  
Bariatric Procedure ◽  
Outcome Analysis ◽  
Long Term Outcome ◽  
The Mean

Laparoscopic sleeve gastrectomy (LSG) has gained support as a single-staged and stand-alone bariatric procedure. Reports of excess weight loss of 35 to 83 per cent, reduction in comorbidities, and decreased operative morbidity have garnered support for LSG. This study represents an initial outcome analysis of LSG performed solely at a military treatment center. This study is a retrospective analysis of all patients receiving LSG at Dwight D. Eisenhower Army Medical Center from September 2007 to December 2009. The patients were planned for a stand-alone procedure. One hundred and fifteen patients received LSG over this time period with a mean body mass index of 45.5 ± 6.2 (range 35.1-58.3). The average age was 47.4 ± 12.5 years. Diabetes mellitus was seen in 47 per cent and 68 per cent of patients had hypertension. The mean and median length of operation was 124 ± 48 and 115.5 minutes. The mean percentage of excess weight loss was 16.6 ± 6.40 per cent at 1 month, 31.5 ± 7.6 per cent at 3 months, 41.2 ± 13.9 per cent at 6 months, and 53.7 ± 12.5 per cent at 1 year from surgery. One or more of patient's preoperative diabetic or hypertensive medications were improved postoperatively in 18.7 per cent and 16.3 per cent, respectively. Incidence of major complications occurred in 4.35 per cent of patients in this study to include four leaks (3.4%), one death (0.87%), and 10 readmissions. Midterm analysis of outcomes related to LSG as a single-stage bariatric procedure is promising as long-term outcome data is collected; the efficacy of this procedure as a sole bariatric procedure will continue to be borne out.

The Effects of Bougie Caliber on Leaks and Excess Weight Loss Following Laparoscopic Sleeve Gastrectomy. Is There an Ideal Bougie Size?

2013 ◽  
Vol 23 (10) ◽  
pp. 1685-1691 ◽  
Author(s):  
Jonathan B. Yuval ◽  
Yoav Mintz ◽  
Matan J. Cohen ◽  
Avraham I. Rivkind ◽  
Ram Elazary
Keyword(s):  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Excess Weight Loss ◽  
Excess Weight ◽  
Bougie Size

scholarly journals The role of the surgical resection distance from the pylorus after laparoscopic sleeve gastrectomy: a prospective cohort study from an academic medical center in Egypt

2020 ◽  
Vol 14 (1) ◽  
Author(s):  
Ahmed H. Hussein ◽  
Islam Khaled ◽  
Mohammed Faisal
Keyword(s):  
Quality Of Life ◽  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Excess Weight Loss ◽  
Excess Weight ◽  
Short Term ◽  
Weight Loss Percentage ◽  
Pylorus Resection

Abstract Background Laparoscopic sleeve gastrectomy was recently described as an effective approach for the operative treatment of obesity, but the ideal procedure remains controversial. One of the most debated issues is the resection distance from the pylorus. We conducted this study to elucidate any potential differences in the short-term outcomes between 2 and 6 cm distance from the pylorus in laparoscopic sleeve gastrectomy. Methods A prospective observational cohort study in a selected cohort of 96 patients was conducted from January 2018 to March 2019 in morbidly obese patients who had laparoscopic sleeve gastrectomy performed at Suez Canal University Hospital. Outcome was expressed by excess weight loss percentage, resolution of comorbidities, improvement of quality of life, and incidence of complications after laparoscopic sleeve gastrectomy. The morbidly obese patients (body mass index [BMI] > 40 kg/m2 or > 35 kg/m2 with obesity-related comorbidities) in the study were divided into two equal groups: (1) Group 1 (48 patients) underwent laparoscopic sleeve gastrectomy with a 2 cm distance from the pylorus resection distance and (2) Group 2 (48 patients) underwent laparoscopic sleeve gastrectomy with a 6 cm distance from the pylorus resection distance. Body weight, BMI, bariatric quality of life, lipid profile, and comorbidities were evaluated pre- and post-operatively for a duration of 12 months. Results Statistically, no significant differences between the two study groups regarding the excess weight loss percentage, comorbidity resolution throughout the postoperative follow-up, enhancement of the quality of life score throughout the postoperative follow-up, or incidence of complications (25% in Group 1 versus 25% in Group 2, p > 0.05) were found. Conclusion Laparoscopic sleeve gastrectomy was an effective and safe management for morbid obesity and obesity-related comorbidities with significant short-term weight loss; it also improved weight-related quality of life and had an acceptable complication rate. The distance from the pylorus resection distance did not affect the short-term effects of laparoscopic sleeve gastrectomy regarding excess weight loss percentage, resolution of comorbidities, change in quality of life, or occurrence of complications.

Nissen Fundoplication–Preserving Laparoscopic Sleeve Gastrectomy

2019 ◽  
Vol 85 (2) ◽  
pp. 173-176 ◽  
Author(s):  
Craig R. Smith ◽  
Jeffrey T. Gardner ◽  
Lexie H. Vaughn ◽  
Robert J. Kelly ◽  
Oliver C. Whipple
Keyword(s):  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Postoperative Complications ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Excess Weight Loss ◽  
Nissen Fundoplication ◽  
Excess Weight ◽  
Concomitant Treatment ◽  
The Mean ◽  
Gerd Symptoms

Gastroesophageal reflux disease (GERD) is significantly more prevalent in obese patients. Nissen fundoplication alleviates symptoms in those refractory to dietary changes and optimal medical management. The need for concomitant treatment of GERD and obesity is becoming more prevalent. The objective of this study was to determine whether Nissen-preserving laparoscopic sleeve gastrectomy (SG) is a safe and effective weight loss option for patients with pre-existing Nissen fundoplication. The study was conducted at the Hospital Corporation of America, Memorial Health, Savannah, Georgia, academic institution. We retrospectively reviewed five patients who underwent laparoscopic Nissen-preserving SG between 2011 and 2017. We compared pre- and postoperative subjective GERD symptoms, occurrence of any immediate postoperative complications, change in BMI, and excess weight loss. Of the five patients, four were female and one was male. The mean age was 50.6 years. The mean preoperative BMI was 44.8 ± 5.4, one-month postoperative BMI was 41.2 ± 6.1 (P < 0.001), and six-month postoperative BMI was 37.5 ± 8.1 (P < 0.009), with mean excess weight loss at six months of 33.9 ± 23 per cent. There were no immediate postoperative complications. Subjective GERD symptoms were unchanged in two patients and improved in the other three. We demonstrate the early feasibility of Nissen-preserving SG for surgical weight loss in patients with existing Nissen fundoplication. Although our results are early, we feel encouraged by mean excess weight loss to date and control of GERD symptoms.

Relationship between monocyte-to-high-density lipoprotein cholesterol ratio and excess weight loss in laparoscopic sleeve gastrectomy

2021 ◽  
Vol 15 (15) ◽  
pp. 1367-1375
Author(s):  
Sibel Ocak Serin ◽  
Abdullah Sisik ◽  
Fatih Basak
Keyword(s):  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
High Density Lipoprotein ◽  
Laparoscopic Sleeve Gastrectomy ◽  
High Density Lipoprotein Cholesterol ◽  
Excess Weight Loss ◽  
Density Lipoprotein ◽  
Excess Weight ◽  
Lipoprotein Cholesterol ◽  
Cholesterol Ratio

Aim: The present study evaluates the relationship between the monocyte-to-high-density lipoprotein cholesterol ratio (MHR) and the percentage of excess weight loss (%EWL) in patients undergoing laparoscopic sleeve gastrectomy. Method: This prospective cohort study evaluated 125 patients who underwent laparoscopic sleeve gastrectomy. The MHR before and at 6 months after surgery were compared in patients with <50 and ≥50 %EWL. Results: The MHR was lower in patients with a %EWL of <50 than in patients with a %EWL of ≥50 (p = 0.019). The decrease in the MHR at postoperative 6 months was more remarkable in patients with a %EWL of ≥50 (p < 0.001). Conclusion: The present study suggests that MHR decreased more remarkably at postoperative 6 months in patients with high %EWL, predicting a decrease in cardiovascular risk.

Sign in / Sign up

Export Citation Format

Share Document